← Leaderboards
Chalet Tan
Emory University
$2,854,595
Attributed
$5,233,206
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2010–24$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$5,233,206 · 6
By mechanism
R01$3,567,917 · 1
U19$1,159,108 · 3
R15$470,658 · 1
F32$35,523 · 1
Top collaborators
- Leo E Otterbein5 shared
- Binghe Wang5 shared
Most similar at Emory University
Same institution · by research overlap
- Stephen F. Traynelis$23,245,799
- H. Criss Hartzell$12,440,886
- Donald G Rainnie$11,984,538
- Douglas C Eaton$36,075,657
- James D Stockand$11,411,584
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoLinkHost DefenseProtective EffectClinical TrialsIn VitroKineticsImmune ResponseMacrophagePropertySeriesPharmacologyDesignDoseAcuteDrug KineticsDependenceAntiinflammatory EffectAnti-Inflammatory AgentsDefectDosageDrug DevelopmentCytoprotectionClostridium Difficile
Grant awards (12)
Unravelling Immune Enhancement by Immulina$181,531
U19 · FY2024 · AT · contact PI
Examining Carbon Monoxide to Treat Inflammatory Conditions using Experimental Colitis Models$708,873
R01 · FY2023 · DK
Unravelling Immune Enhancement by Immulina$161,469
U19 · FY2023 · AT · contact PI
Examining Carbon Monoxide to Treat Inflammatory Conditions using Experimental Colitis Models$708,873
R01 · FY2022 · DK
Unravelling Immune Enhancement by Immulina$172,969
U19 · FY2022 · AT · contact PI
Examining Carbon Monoxide to Treat Inflammatory Conditions using Experimental Colitis Models$708,873
R01 · FY2021 · DK
Unravelling Immune Enhancement by Immulina$318,572
U19 · FY2021 · AT · contact PI
Examining Carbon Monoxide to Treat Inflammatory Conditions using Experimental Colitis Models$707,948
R01 · FY2020 · DK
Unravelling Immune Enhancement by Immulina$324,567
U19 · FY2020 · AT · contact PI
Examining Carbon Monoxide to Treat Inflammatory Conditions using Experimental Colitis Models$733,350
R01 · FY2019 · DK
Functionalized Micellar Nanocarriers for Targeted Cancer Therapy$470,658
R15 · FY2010 · CA · contact PI
Therapeutic modulation with thrombospondin-1$35,523
F32 · FY2004 · CA